Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia

Background: The emergence and resurgence of zoonotic diseases have continued to be a major threat to global health and the economy. Developing countries are particularly vulnerable due to agricultural expansions and domestication of animals with humans. Scientifically sound clinical trials are impor...

Full description

Bibliographic Details
Main Authors: Senait Belay, Mirutse Giday, Tsegahun Manyazewal
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.621433/full
_version_ 1818329560778801152
author Senait Belay
Senait Belay
Mirutse Giday
Mirutse Giday
Tsegahun Manyazewal
author_facet Senait Belay
Senait Belay
Mirutse Giday
Mirutse Giday
Tsegahun Manyazewal
author_sort Senait Belay
collection DOAJ
description Background: The emergence and resurgence of zoonotic diseases have continued to be a major threat to global health and the economy. Developing countries are particularly vulnerable due to agricultural expansions and domestication of animals with humans. Scientifically sound clinical trials are important to find better ways to prevent, diagnose, and treat zoonotic diseases, while there is a lack of evidence to inform the clinical trials' capacity and practice in countries highly affected with the diseases. This study aimed to investigate expert scientists' perceptions and experiences in conducting clinical trials toward zoonotic diseases in Ethiopia.Methods: This study employed a descriptive, qualitative study design. It included major academic and research institutions in Ethiopia that had active engagements in veterinary and public health researches. It included the National Veterinary Institute, the National Animal Health Diagnostic and Investigation Center, the College of Veterinary Medicine at Addis Ababa University, the Ethiopian Public Health Institute, the Armauer Hansen Research Institute, and the College of Health Sciences at Addis Ababa University. In-depth interviews were conducted with expert scientists. Data were collected from October 2019 to April 2020. Data analysis was undertaken using open code 4.03 for qualitative data analysis.Results: Five major themes, with 18 sub-themes, emerged from the in-depth interviews. These were: challenges in the prevention, control, and treatment of zoonotic diseases; One Health approach to mitigate zoonotic diseases; personal and institutional experiences in conducting clinical trials on zoonotic diseases; barriers in conducting clinical trials toward zoonotic diseases; and strategies that promote conducting clinical trials on zoonotic diseases. Conducting clinical trials on zoonotic diseases in Ethiopia is hampered by a lack of clearly articulated ethics and regulatory frameworks, trial experts, financial resources, and good governance.Conclusion: In Ethiopia, conducting clinical trials on zoonotic diseases deserves due attention. Strengthening institutional and human resources capacity is a pre-condition to harness effective implementation of clinical trials on zoonotic diseases in the country. In Ethiopia where skilled human resource is scarce, One Health approach has the potential to form multidisciplinary teams to systematically improve clinical trials capacity and outcomes in the country.
first_indexed 2024-12-13T12:50:00Z
format Article
id doaj.art-d48539b081814554b998645045d31fdc
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-12-13T12:50:00Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-d48539b081814554b998645045d31fdc2022-12-21T23:45:21ZengFrontiers Media S.A.Frontiers in Public Health2296-25652021-04-01910.3389/fpubh.2021.621433621433Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in EthiopiaSenait Belay0Senait Belay1Mirutse Giday2Mirutse Giday3Tsegahun Manyazewal4Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, EthiopiaFaculty of Veterinary Medicine, Hawassa University, Hawassa, EthiopiaCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, EthiopiaAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, EthiopiaCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, EthiopiaBackground: The emergence and resurgence of zoonotic diseases have continued to be a major threat to global health and the economy. Developing countries are particularly vulnerable due to agricultural expansions and domestication of animals with humans. Scientifically sound clinical trials are important to find better ways to prevent, diagnose, and treat zoonotic diseases, while there is a lack of evidence to inform the clinical trials' capacity and practice in countries highly affected with the diseases. This study aimed to investigate expert scientists' perceptions and experiences in conducting clinical trials toward zoonotic diseases in Ethiopia.Methods: This study employed a descriptive, qualitative study design. It included major academic and research institutions in Ethiopia that had active engagements in veterinary and public health researches. It included the National Veterinary Institute, the National Animal Health Diagnostic and Investigation Center, the College of Veterinary Medicine at Addis Ababa University, the Ethiopian Public Health Institute, the Armauer Hansen Research Institute, and the College of Health Sciences at Addis Ababa University. In-depth interviews were conducted with expert scientists. Data were collected from October 2019 to April 2020. Data analysis was undertaken using open code 4.03 for qualitative data analysis.Results: Five major themes, with 18 sub-themes, emerged from the in-depth interviews. These were: challenges in the prevention, control, and treatment of zoonotic diseases; One Health approach to mitigate zoonotic diseases; personal and institutional experiences in conducting clinical trials on zoonotic diseases; barriers in conducting clinical trials toward zoonotic diseases; and strategies that promote conducting clinical trials on zoonotic diseases. Conducting clinical trials on zoonotic diseases in Ethiopia is hampered by a lack of clearly articulated ethics and regulatory frameworks, trial experts, financial resources, and good governance.Conclusion: In Ethiopia, conducting clinical trials on zoonotic diseases deserves due attention. Strengthening institutional and human resources capacity is a pre-condition to harness effective implementation of clinical trials on zoonotic diseases in the country. In Ethiopia where skilled human resource is scarce, One Health approach has the potential to form multidisciplinary teams to systematically improve clinical trials capacity and outcomes in the country.https://www.frontiersin.org/articles/10.3389/fpubh.2021.621433/fullclinical trialzoonotic diseaseEthiopiaone healthhuman resources
spellingShingle Senait Belay
Senait Belay
Mirutse Giday
Mirutse Giday
Tsegahun Manyazewal
Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia
Frontiers in Public Health
clinical trial
zoonotic disease
Ethiopia
one health
human resources
title Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia
title_full Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia
title_fullStr Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia
title_full_unstemmed Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia
title_short Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia
title_sort harnessing clinical trial capacity to mitigate zoonotic diseases the role of expert scientists in ethiopia
topic clinical trial
zoonotic disease
Ethiopia
one health
human resources
url https://www.frontiersin.org/articles/10.3389/fpubh.2021.621433/full
work_keys_str_mv AT senaitbelay harnessingclinicaltrialcapacitytomitigatezoonoticdiseasestheroleofexpertscientistsinethiopia
AT senaitbelay harnessingclinicaltrialcapacitytomitigatezoonoticdiseasestheroleofexpertscientistsinethiopia
AT mirutsegiday harnessingclinicaltrialcapacitytomitigatezoonoticdiseasestheroleofexpertscientistsinethiopia
AT mirutsegiday harnessingclinicaltrialcapacitytomitigatezoonoticdiseasestheroleofexpertscientistsinethiopia
AT tsegahunmanyazewal harnessingclinicaltrialcapacitytomitigatezoonoticdiseasestheroleofexpertscientistsinethiopia